{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/mrsa-in-primary-care/how-this-topic-was-developed/stakeholder-engagement/","result":{"pageContext":{"chapter":{"id":"aea98085-ac9a-5b4c-a54b-a8857e1055e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement","depth":2,"htmlHeader":"<!-- begin field f9e189ac-8313-4f31-8384-a7f2017682e7 --><h2>Stakeholder engagement</h2><!-- end field f9e189ac-8313-4f31-8384-a7f2017682e7 -->","summary":null,"htmlStringContent":"<!-- begin item e754a126-c7a3-4087-bc93-a7f20174d91e --><!-- begin field 17100d4a-ca29-4008-b937-a7f2017682e7 --><h2>Our policy</h2><!-- end field 17100d4a-ca29-4008-b937-a7f2017682e7 --><!-- begin field a8d0ab03-650a-4ce4-880a-a7f2017682e7 --><p>The external review process is an essential part of CKS topic development. Consultation with a wide range of stakeholders provides quality assurance of the topic in terms of:</p><ul><li>Clinical accuracy.</li><li>Consistency with other providers of clinical knowledge for primary care.</li><li>Accuracy of implementation of national guidance (in particular NICE guidelines).</li><li>Usability.</li></ul><!-- end field a8d0ab03-650a-4ce4-880a-a7f2017682e7 --><!-- begin field f13f346a-af67-496f-8552-a7f2017682e7 --><h2>Principles of the consultation process</h2><!-- end field f13f346a-af67-496f-8552-a7f2017682e7 --><!-- begin field a7dd3a1a-d2c6-4978-a30f-a7f2017682e7 --><ul><li>The process is inclusive and any individual may participate.</li><li>To participate, an individual must declare whether they have any competing interests or not. If they do not declare whether or not they have competing interests, their comments will not be considered.</li><li>Comments received after the deadline will be considered, but they may not be acted upon before the clinical topic is issued onto the website.</li><li>Comments are accepted in any format that is convenient to the reviewer, although an electronic format is encouraged.</li><li>External reviewers are not paid for commenting on the draft topics.</li><li>Discussion with an individual or an organization about the CKS response to their comments is only undertaken in exceptional circumstances (at the discretion of the Clinical Editor or Editorial Steering Group).</li><li>All reviewers are thanked and offered a letter acknowledging their contribution for the purposes of appraisal/revalidation.</li><li>All reviewers are invited to be acknowledged on the website. All reviewers are given the opportunity to feedback about the external review process, enabling improvements to be made where appropriate.</li></ul><!-- end field a7dd3a1a-d2c6-4978-a30f-a7f2017682e7 --><!-- begin field aee9bc99-59bc-4740-80ee-a7f2017682e7 --><h2>Stakeholders</h2><!-- end field aee9bc99-59bc-4740-80ee-a7f2017682e7 --><!-- begin field 10245f04-86ff-48e4-8dda-a7f2017682e7 --><ul><li>Key stakeholders identified by the CKS team are invited to comment on draft CKS topics. Individuals and organizations can also register an interest to feedback on a specific topic, or topics in a particular clinical area, through the <a href=\"http://cks.clarity.co.uk/get-involved/\" data-hyperlink-id=\"2da0b530-1bf6-4207-b7a1-a9910178dbe8\">Getting involved</a> section of the <a href=\"https://clarity.co.uk/\" data-hyperlink-id=\"259b0847-45e7-4e77-9bf2-a9910178dcbd\">Clarity Informatics</a> website.</li><li>Stakeholders identified from the following groups are invited to review draft topics:<ul><li>Experts in the topic area.</li><li>Professional organizations and societies (for example, Royal Colleges).</li><li>Patient organizations, Clarity has established close links with groups such as Age UK and the Alzheimer’s Society specifically for their input into new topic development, review of current topic content and advice on relevant areas of expert knowledge.</li><li>Guideline development groups where the topic is an implementation of a guideline.</li><li>The British National Formulary team.</li><li>The editorial team that develop MeReC Publications.</li></ul></li><li>Reviewers are provided with clear instructions about what to review, what comments are particularly helpful, how to submit comments, and declaring interests.</li></ul><!-- end field 10245f04-86ff-48e4-8dda-a7f2017682e7 --><!-- begin field ecd6eb3b-bbe6-458e-9351-a7f2017682e7 --><h2>Patient engagement</h2><!-- end field ecd6eb3b-bbe6-458e-9351-a7f2017682e7 --><!-- begin field 3715dc7b-cbac-429c-a794-a7f2017682e7 --><p>Clarity Informatics has enlisted the support and involvement of patients and lay persons at all stages in the process of creating the content which include:</p><ul><li>Topic selection</li><li>Scoping of topic</li><li>Selection of clinical scenarios</li><li>First draft internal review</li><li>Second draft internal review</li><li>External review</li><li>Final draft and pre-publication</li></ul><p>Our lay and patient involvement includes membership on the editorial steering group, contacting expert patient groups, organizations and individuals.</p><!-- end field 3715dc7b-cbac-429c-a794-a7f2017682e7 --><!-- end item e754a126-c7a3-4087-bc93-a7f20174d91e -->","topic":{"id":"26f48611-f890-5112-aa26-bef13e5623e1","topicId":"c9e197be-4f79-4d67-bf67-2b2a8a137e03","topicName":"MRSA in primary care","slug":"mrsa-in-primary-care","lastRevised":"Last revised in October 2018","chapters":[{"id":"ba15ac05-528a-5474-8925-89cfea95b961","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"97d099f9-1263-51e7-8c71-fb82256182d3","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f6df2380-e42f-563b-8f75-a588376e1da7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"530a7f74-53c2-5e4e-8c1d-ceb01bccf776","slug":"changes","fullItemName":"Changes"},{"id":"a17267d5-eb08-5126-9312-b78fee4494a2","slug":"update","fullItemName":"Update"}]},{"id":"9537a389-c41a-5355-ac9c-9c56bba48a35","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"124fbaa7-2678-5958-b4be-d5f9be74c18a","slug":"goals","fullItemName":"Goals"},{"id":"4a1ce510-f22c-5132-a344-31bd40831eac","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"8e5d44fe-1deb-51e2-bb59-04ccc35710c7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4b396bfd-befc-5055-a086-61c9628b6042","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"db6fe095-36c1-5949-87a9-e1c049f58234","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e5c4d5c6-ed37-5a97-a1ef-874a072dd190","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ab09ceb7-2cc4-57c7-a6ec-887e4df64336","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"25bf5688-a664-56d4-b6cd-077f06dc4be5","slug":"definition","fullItemName":"Definition"},{"id":"d85a2164-704c-52e3-b5f8-2170aa56ead6","slug":"causes","fullItemName":"Causes"},{"id":"06951cf4-8eb9-5dc4-89be-8f9d5c691a2c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e6f67db6-38d0-57cd-a3fa-15d68e43e3a3","slug":"prognosis","fullItemName":"Prognosis"},{"id":"26204955-9976-5215-8ba5-fb73d7b50a95","slug":"complications","fullItemName":"Complications"}]},{"id":"41a2bada-cc7d-5a86-9495-82d662957b3a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d4b618cd-66fe-50a0-a686-99007ef42fc3","slug":"when-to-suspect-mrsa","fullItemName":"When to suspect MRSA"},{"id":"8c893fa3-9e5e-5db1-87f3-370e7e9afd70","slug":"assessment","fullItemName":"Assessment"},{"id":"01c6eee3-9b6f-5c05-8f49-c30279e03ddf","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4d78ace1-1174-5c0f-b2e6-c74c8a51847a","fullItemName":"Management","slug":"management","subChapters":[{"id":"ddb73bdb-86dd-524d-92b2-f92b0ca957a0","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"a6c4d845-e78e-5116-b950-e78374132545","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9eb97cdf-d2a2-5018-9667-43dbca0cb266","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"ef38f185-0695-523f-bf60-bd75e123a75e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"aea98085-ac9a-5b4c-a54b-a8857e1055e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"795e0448-4ce8-5b2a-8a85-3aa1ecac9c40","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"834f64f0-6780-5945-914d-8f8a0d4e8dfe","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"7c573460-655d-5212-8d3c-fb5758d25c43","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"43afc1fb-06c4-5ec8-9051-d49b5156cfc6","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9eb97cdf-d2a2-5018-9667-43dbca0cb266","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}